There are about 60 million people with diabetes in the European Region. After 15 years with diabetes, approximately 2% will go blind from diabetic retinopathy, and about 10% will develop severe visual impairment. (World Health Organization)
• Proven to be effective in real-world clinical workflows
• Results in less than a minute - no human grader
• Clinically validated with high sensitivity and specificity
Immediate image quality feedback enables even novice users to capture the high quality images needed for accurate disease detection, reducing the number of patient call-backs.
IDx is partnered with Medical Workshop in the Netherlands and IBM Watson Health across the rest of the EU for distribution of IDx-DR.